Abortion medication access, like mifepristone, is unchanged under Trump, but FDA reviews, lawsuits and state enforcement are creating risks for drugmakers.
The Food and Drug Administration has delayed a promised review of safety data for the abortion drug mifepristone at ...
Two state lawmakers are sparring over how to enshrine protections in state law for women who have miscarriages or other ...
Following a pressure campaign from anti-abortion groups, Makary and Health and Human Services Secretary Robert F. Kennedy Jr.
Marjorie Dannenfelser called for FDA Commissioner Marty Makary to be fired for allegedly delaying a mifepristone safety ...
The ballot measure also includes a ban on gender affirming health care for minors. Judges reissued the summary statement that ...
Maine Gov. Janet Mills, known for advancing abortion rights, receives a key endorsement for her 2026 Senate bid against incumbent Susan Collins.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback